Head of Business Development, Marketing - CRO Quality & Release

• 2019 - Present

Currently, in this role, I develop and implement strategic initiatives to direct and coach a team consisting of four Business Developers, one Business Support Leader, Five Business Support Officers, and temporary staff. In addition to implementing innovative plans, BD-Tools, and processes across the Chemical, Biological, and High Through-put (4) business units, I formulate and execute enhanced workflows, oversee contracting, and monitor markets to target new business opportunities.Furthermore, I devise and establish business development priorities/processes and drive customer conversion rates in alignment with four business units and the European Dir. Leadership team that consists of 45 business units. Other duties include conducting impact assessments to develop new approaches for organisational change management (OCM) and to boost employee engagement. Finally, I coordinate Rewards and Recognition programs for the BD Team and support Human Resource (HR) processes including hiring/recruitment and staff training and development.Selected Achievements:· Advanced to positions of increasing scope and responsibility from Director of Sales and Marketing in 2019 to Head of Business Development and Marketing in 2020.· Influential and orchestrating development of Business Department from four to 10-12 team members and 2-4 temps.· Recognised for effectively implementing conceptual selling methodologies to mitigate/resolve prospect’s issues, aligned with operational services and goals. Show less

Director Sales & Marketing

• 2019 - 2020

Global Head Business Operations and Business Development – CRO Central

• 2015 - 2019

This role allowed me to direct a team (20-26) including four Business Developers and professionals in Contracts and Proposals, Finance, one PA, temporary hires/consultants, seven senior-level global Business Developers, and Global CRO-Clinical Phase I-IV Executive with skills in sales management, business operations, and finance. Leveraging my expertise I conducted best practice research to pinpoint benchmarks to devise and execute strategic marketing, sales, and change management initiatives in alignment with enterprise and business development goals. Finally, I cultivated and nurtured strategic alliances as well as identified and acted upon lucrative business development and sales opportunities to boost the current portfolio including ROI (return of investment), and market share. Selected Achievements: · Generated €50M in global revenue. · Implemented a new CRM system. · Increased output of proposals by >50% from 330 in 2017 to 670 in 2018 Show less

Sr. Director of Business Development – CRO Pre-Clinical

• 2012 - 2015

As the Senior Director of Business Development - CRO Pre-Clinical, I cultivated a collaborative, multi-cultural, and inclusive work culture for internal/external teams across various time zones. Moreover, I reported to the Global VP and drove initiatives to direct rapid new business/market expansion. Finally, I spearheaded pre-clinical and lab services key accounts, leveraging my business/financial acumen and partnership strategies to develop forecasts and strategic pricing as well as coordinate internal/external negotiations. Selected Achievements: · Advanced to position of increasing scope and responsibility from Business Development Manager in 2012 to Sr. Director of Business Development in 2013. · Served as pre-clinical US strategic pricing team member. · Achieved consistent and on target growth. Show less

Business Development Manager - CRO Pre-Clinical

• 2012 - 2013

In this position, I geared strategic plans in alignment with the enterprise roadmap to coordinate business development, key accounts, and develop teams. Furthermore, I facilitated pre-clinical contract research services for pharmaceutical and veterinary pharmaceuticals. In addition to identifying opportunities, I validated their eligibility and secured new business opportunities across the Pharmaceutical, Biotechnology, and Academic sectors. Moreover, I guaranteed cohesive process management to support and sell bespoke proposals. Finally, I developed and nurtured customer relations to drive customer engagement, utilising my interpersonal skills to interact/liaise with decision-makers and develop international relations. Selected Achievements: · Established territory sales, price negotiation, and marketing strategies that generated and secured new leads. · Developed and implemented educational programs to drive quality across strategic selling, negotiations, and implementation of marketing initiatives. Show less

International Sales and Business Developer – CRO Pre-Clinical

• Aug 2009 - 2012

This role allowed me to develop and implement sales and new business development strategies in areas of emerging innovations and services for Pharmaceutical and Biotech companies supplying contract research, project support, and co-development. Moreover, I conducted best practice research and market analysis to harness data-driven insights from key metrics such as customer insights and trends to gather market intelligence and boost positioning. Finally, I directed forecasting, quotations, internal/external cross-functional relations, and the recruitment of multidisciplinary support teams. Selected Achievements: · Achieved 2011 highest recorded sales in 10 years, totalling €7M. Show less

Corporate Portfolio Manager – Big Pharma MLS

• 2008 - 2009

As a Corporate Portfolio Manager, I led key corporate accounts including impactful organisational change management initiatives and cross-functional relations to drive profitability in areas of newly developed knowledge and services. Other duties included developing and implementing efficient area network plans to generate new leads including sales strategies to maximise ROI. Moreover, I governed DMU, hospital portfolio, new product pre-launch development, and post (clinical) marketing surveillance. Finally, I prepared and delivered monthly reports to senior management and cultivated relations with KOL (Key Opinion Leaders) from cooperatives and/or networks. Show less